organophosphonates has been researched along with Pneumonia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balbekova, A; Großgarten, M; Holzlechner, M; Karst, U; Lendl, B; Marchetti-Deschmann, M; Sperling, M; Vennemann, A; Wieland, K; Wiemann, M | 1 |
| Hong, DJ; Jhun, BW; Kim, K; Kim, SJ; Park, SB | 1 |
| Gerna, G; Lilleri, D | 1 |
| Cadranel, J; Gharbi, N; Gille, T; Khalil, A; Le Tinier, JY; Rivière, F; Wislez, M | 1 |
| Drew, WL; Lalezari, JP | 1 |
| Bray, M; Huggins, JW; Kefauver, D; Martinez, M; Smee, DF; Thompson, E | 1 |
| Torres, G | 1 |
2 review(s) available for organophosphonates and Pneumonia
| Article | Year |
|---|---|
Strategies to control human cytomegalovirus infection in adult hematopoietic stem cell transplant recipients.
Topics: Acetates; Adult; Animals; Antiviral Agents; Asymptomatic Diseases; Benzimidazoles; Clinical Trials as Topic; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease Management; Gastroenteritis; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy; Monitoring, Immunologic; Organophosphonates; Pneumonia; Postoperative Complications; Quinazolines; Ribonucleosides | 2016 |
Cytomegalovirus: disease syndromes and treatment.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Central Nervous System Diseases; Chorioretinitis; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance; Foscarnet; Ganciclovir; Gastrointestinal Diseases; Humans; Organophosphonates; Organophosphorus Compounds; Pneumonia; Sexually Transmitted Diseases, Viral | 1999 |
1 trial(s) available for organophosphonates and Pneumonia
| Article | Year |
|---|---|
Opportunistic infection highlights from the 35th ICAAC.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Bacterial Vaccines; CD4 Lymphocyte Count; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Ganciclovir; HIV; Humans; Influenza Vaccines; Mycobacterium avium-intracellulare Infection; Organophosphonates; Organophosphorus Compounds; Pneumonia; Pneumonia, Pneumocystis; Randomized Controlled Trials as Topic; United States; Valacyclovir; Valine; Viremia | 1995 |
4 other study(ies) available for organophosphonates and Pneumonia
| Article | Year |
|---|---|
Phosphonate coating of SiO
Topics: Animals; Biomarkers; Bronchoalveolar Lavage Fluid; Cell Line; Female; Inhalation Exposure; Lung; Macrophages, Alveolar; Microscopy, Fluorescence; Nanoparticles; Organophosphonates; Phospholipids; Pneumonia; Rats, Wistar; Silicon Dioxide; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spectroscopy, Fourier Transform Infrared; Tandem Mass Spectrometry | 2018 |
Outcomes of early administration of cidofovir in non-immunocompromised patients with severe adenovirus pneumonia.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Cidofovir; Cytosine; Drug-Related Side Effects and Adverse Reactions; Humans; Immunocompromised Host; Medical Records; Organophosphonates; Pneumonia; Respiratory Insufficiency; Retrospective Studies; Treatment Outcome | 2015 |
Treatment of recurrent respiratory papillomatosis lung involvement by cidofovir infusion.
Topics: Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Infusions, Intravenous; Lung; Middle Aged; Organophosphonates; Papillomavirus Infections; Pneumonia; Respiratory Function Tests; Respiratory Tract Infections; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge.
Topics: Administration, Intranasal; Aerosols; Animals; Antiviral Agents; Bronchi; Cidofovir; Cowpox; Cytosine; Female; Hemorrhage; Mice; Mice, Inbred BALB C; Mice, SCID; Organophosphonates; Organophosphorus Compounds; Pneumonia; Pulmonary Alveoli; Smallpox; Vaccination | 2000 |